X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-14 | MTEM | Biotech Target N V | 10% | S - Sale+OE | $0.66 | -1,279,820 | 0 | -100% | -$845,833 | |||||
| D | 2024-04-02 | MTEM | Biotech Target N V | 10% | P - Purchase | $2.35 | +250,000 | 1,279,820 | +24% | +$587,500 | |||||
2023-07-17 | MTEM | Biotech Target N V | 10% | P - Purchase | $0.47 | +4,255,319 | 15,447,322 | +38% | +$2,000,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |